Toshiba America Medical Systems, Inc. announced the enrollment of 400 patients in its CorE 64 (Coronary Evaluation on 64) study taking place across seven countries, evaluating the use of 64-slice CT technology.

Toshiba’s CorE 64 trial investigates the use of multi-slice CT as a diagnostic tool for detecting cardiovascular diseases and disorders, as compared to cardiac catheterization. Data collected to date from CorE 64 indicates CT as a diagnostic alternative to cardiac catheterization and has the potential to change the delivery of healthcare. 

“We expect CorE 64 findings to impact the overall reimbursement guidelines for multi-slice CT, resulting in greater patient access to these exams and to have significant economic benefits for 64-slice CT,” explained Toshihiro Rifu, senior fellow, Toshiba Medical Systems Corporation. 

The CorE 64 multi-center study participants include nine sites across seven countries:

• Johns Hopkins University School of Medicine, in Baltimore, Md., led by primary investigators Drs. João A. C. Lima and Julie Miller;
• Johns Hopkins Bayview Medical Center in Baltimore, Md.;
• Beth Israel Deaconess Medical Center at Harvard in Boston, Mass.;
• Leiden University Medical Center in the Netherlands;
• Humboldt University, Campus Charité Mitte in Germany;
• INCOR Heart Institute of the School of Medicine Hospital, Sao Paulo University in Brazil;
• Iwate Medical University in Japan;
• Mount Elizabeth Hospital in Singapore; and
• Toronto General Hospital, University Health Network and Mount Sinai Hospital in Canada.

For more information about CorE 64, please visit www.medical.toshiba.com